Perspective Therapeutics, Inc.
CATX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$79,279 | -$46,508 | -$14,670 | -$7,272 |
| Dep. & Amort. | $2,306 | $946 | $344 | $248 |
| Deferred Tax | -$2,097 | -$2,651 | -$1,682 | $0 |
| Stock-Based Comp. | $5,387 | $3,738 | $1,344 | $1,087 |
| Change in WC | $0 | $2,296 | $338 | -$1,850 |
| Other Non-Cash | $55,389 | $5,266 | $472 | $77 |
| Operating Cash Flow | -$18,294 | -$36,913 | -$12,172 | -$7,710 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$54,414 | -$1,072 | -$302 | -$266 |
| Net Acquisitions | $0 | $2,699 | $0 | $0 |
| Inv. Purchases | -$243,510 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $22,764 | $0 | $0 |
| Other Inv. Act. | $78,993 | -$18 | -$57,376 | -$18 |
| Investing Cash Flow | -$218,931 | $24,373 | -$57,678 | -$284 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$68 | – | – |
| Stock Issued | $275,807 | $364 | $0 | $56 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $289,385 | $489 | $56 | $0 |
| Financing Cash Flow | $289,385 | $785 | $56 | $56 |
| Forex Effect | $0 | $0 | $61,856 | $0 |
| Net Chg. in Cash | $52,160 | -$46,652 | $182 | -$7,938 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,420 | $21,175 | $55,890 | $64,010 |
| End Cash | $61,580 | $9,420 | $56,072 | $56,072 |
| Free Cash Flow | -$72,708 | -$37,985 | -$12,474 | -$7,976 |